# Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS(L), US-Humalog®, and EU-Humalog®

> **NCT07165652** · PHASE1 · COMPLETED · sponsor: **Xentria, Inc.** · enrollment: 54 (actual)

## Conditions studied

- Healthy Male Adult Volunteers

## Interventions

- **DRUG:** NKF-INS(L)
- **DRUG:** US-Humalog®
- **DRUG:** EU-Humalog®

## Key facts

- **NCT ID:** NCT07165652
- **Lead sponsor:** Xentria, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-10-13
- **Primary completion:** 2026-03-02
- **Final completion:** 2026-03-02
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07165652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07165652, "Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS(L), US-Humalog®, and EU-Humalog®". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07165652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*